Clinical Trial Update: Concomitant Longitudinal Evaluation of Adalimumab With Methotrexate in the Real World: the CLEAR Study [Phase 3]

View source ↗

Summary

Phase 3 real-world study update evaluating the combination of adalimumab with methotrexate in psoriasis (the CLEAR Study) completed with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Humira (adalimumab)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: AbbVie | Conditions: Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2018-03-19